How Delta-9-THCP Was Discovered
Delta-9-THCP (Delta-9-Tetrahydrocannabiphorol) is one of the most recent additions to the growing list of cannabinoids found in the cannabis plant. First identified by Italian researchers in 2019, this compound was discovered during an in-depth analysis of cannabis varieties using advanced technology. The team was investigating the chemical diversity of the plant beyond well-known cannabinoids like CBD and THC, aiming to uncover new molecules that might contribute to the plant's effects.
The discovery of Delta-9-THCP was significant because it revealed a cannabinoid with a structure closely related to Delta-9-THC, the primary psychoactive component in cannabis. However, Delta-9-THCP stands out due to subtle but meaningful differences in its molecular makeup, which could impact how it interacts with the human body.
Understanding the Chemistry of Delta-9-THCP
Delta-9-THCP shares much of its chemical backbone with Delta-9-THC. Both molecules are composed of hydrogen, carbon, and oxygen atoms arranged in similar patterns. The crucial distinction lies in the length of the alkyl side chain—a part of the molecule that influences how it binds to cannabinoid receptors in the body.
- Delta-9-THC: Features a five-carbon side chain.
- Delta-9-THCP: Has a seven-carbon side chain, making it structurally longer.
This longer side chain is not just a scientific curiosity. Early laboratory tests have shown that the seven-carbon chain allows Delta-9-THCP to bind more effectively to CB1 receptors in the body's endocannabinoid system. These receptors are primarily responsible for mediating the effects of cannabinoids on mood, perception, and other physiological processes.
What Makes Delta-9-THCP Unique?
The enhanced binding affinity of Delta-9-THCP means it may have a stronger effect at lower concentrations compared to Delta-9-THC. In animal studies, researchers observed that even small amounts of Delta-9-THCP produced effects similar to or stronger than those seen with higher doses of Delta-9-THC. However, it is important to note that these findings are preliminary and mostly limited to laboratory settings. The real-world impact on humans is still unclear, as comprehensive clinical research is lacking.
Early Research Into Delta-9-THCP's Effects
Scientific understanding of Delta-9-THCP is still in its infancy. Most available data comes from laboratory and animal studies, with very few direct studies involving humans. Initial findings suggest that Delta-9-THCP may interact with the endocannabinoid system in ways that resemble but potentially exceed the effects of Delta-9-THC.
Researchers have noted:
- High potency at cannabinoid receptors: Delta-9-THCP appears to activate CB1 receptors more strongly than Delta-9-THC.
- Potential for pronounced effects: This could mean that even trace amounts of Delta-9-THCP in a cannabis sample might influence its overall effect profile.
Despite these intriguing properties, there is not enough clinical evidence to draw firm conclusions about how Delta-9-THCP affects humans. Variables such as dosage, method of consumption, and individual physiology may all play a role.
What Do We Know About Safety and Side Effects?
Given the novelty of Delta-9-THCP, its safety profile has not been well established. In animal studies, high-affinity binding to CB1 receptors suggests the possibility of strong psychoactive effects. This raises questions about potential side effects, especially in comparison to Delta-9-THC, which is already known for its potent psychoactivity.
Possible considerations include:
- Psychoactive intensity: Delta-9-THCP could produce more intense effects than THC at similar or lower doses.
- Unknown long-term effects: There is currently no data on the long-term impact of Delta-9-THCP use in humans.
- Individual variability: As with all cannabinoids, effects may differ substantially from person to person.
For these reasons, experts recommend caution with products claiming to contain Delta-9-THCP. More research is needed to understand its safety and effects.
Legal Status of Delta-9-THCP
Because Delta-9-THCP was only recently discovered, its legal status is not always clear. Most cannabis regulations worldwide refer specifically to Delta-9-THC and may not mention Delta-9-THCP by name. In some jurisdictions, any substance structurally similar to Delta-9-THC could be regulated the same way, but this varies widely.
- Europe and the UK: Laws tend to focus on Delta-9-THC content, but broader analog laws may include Delta-9-THCP.
- United States: The 2018 Farm Bill legalized hemp-derived cannabinoids with less than 0.3% Delta-9-THC, but compounds like Delta-9-THCP may fall into a legal gray area.
As research continues and the presence of Delta-9-THCP in consumer products becomes more common, regulations may evolve. For now, consumers should check local laws and be cautious when encountering products that advertise rare cannabinoids.
The Future of Delta-9-THCP Research
As interest in cannabis science grows, Delta-9-THCP is likely to attract more research attention. Scientists are eager to explore its potential, both for understanding the complexity of the cannabis plant and for possible future applications. However, it is important to approach new cannabinoids like Delta-9-THCP with a sense of balance—recognizing the excitement around discovery while waiting for thorough, peer-reviewed studies to clarify their properties and safety.
At this stage, Delta-9-THCP remains a fascinating molecule with much left to learn. Anyone interested in rare cannabinoids should stay informed and seek out reliable information as the field evolves.
Latest news
Certifications and Quality Labels for CBD Products
CBD and the Endocannabinoid System: How They Work Together in the Body
Emerging Trends and Innovations Shaping the Future of CBD

Subscribe to our newsletter. Don't miss.
Receive the latest information on sales, special offers, new publications and more...